Biomarkers in Lung Cancer: Barriers to Implementation

Episode
204 - English
Soundcloud
Share

The IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2017 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in eight different languages. In this episode, Dr. Stephen Liu discusses the importance of this survey and some of the barriers to biomarker testing with Dr. Debora Bruno, Dr. Rami Manochakian, and Dr. Matthew Smeltzer. To take the survey, visit: https://bit.ly/BiomarkerS24

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Debora Bruno
Debora Bruno

MD

Medical Director
University Hospitals Dahms Clinical Research Unit
Assistant Professor of Medicine, Case Western Reserve University
Rami Manochakian
Rami Manochakian

MD

Thoracic Oncologist, Associate Professor of Medicine, Vice-Chair of Hematology/Oncology Division
Mayo Clinic Florida
Matthew Smeltzer
Matthew Smeltzer

PhD, MStat

Associate Professor, Division of Epidemiology, Biostatistics, and Environmental Health
University of Memphis